These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34236019)

  • 21. Impact of the introduction of nucleic acid amplification testing on Clostridioides difficile detection and ribotype distribution in Wales.
    Perry MD; White PL; Morris TE
    Anaerobe; 2021 Feb; 67():102313. PubMed ID: 33309680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes.
    Yepez Guevara EA; Aitken SL; Olvera AV; Carlin L; Fernandes KE; Bhatti MM; Garey KW; Adachi J; Okhuysen PC
    Clin Infect Dis; 2021 May; 72(10):e460-e465. PubMed ID: 32803229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
    Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
    J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can a toxin gene NAAT be used to predict toxin EIA and the severity of
    Garvey MI; Bradley CW; Wilkinson MAC; Holden E
    Antimicrob Resist Infect Control; 2017; 6():127. PubMed ID: 29270290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates.
    Alrawashdeh M; Rhee C; Hsu H; Wang R; Horan K; Lee GM
    JAMA Netw Open; 2021 Oct; 4(10):e2132114. PubMed ID: 34714336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric Clostridioides difficile Infection: Diagnosis and Diagnostic Stewardship.
    Schwenk HT; Pollock NR; Vaughan-Malloy AM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S16-S21. PubMed ID: 34791395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Description of antibiotic treatment in adults tested for Clostridioides difficile infection: a single-center case-control study.
    Kim MH; Kim YC; Kim JL; Park YS; Kim H
    BMC Infect Dis; 2022 Jan; 22(1):104. PubMed ID: 35093016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-world evaluation of a two-step testing algorithm for
    Hecker MT; Son AH; Zuccaro P; Conti J; Donskey CJ
    Infect Control Hosp Epidemiol; 2023 Sep; 44(9):1494-1496. PubMed ID: 36750229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing
    Magro M; Rosenberg J; Epson E
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):292-297. PubMed ID: 32993820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
    Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between
    Evans ME; McCauley BP; Simbartl LA
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1940-1941. PubMed ID: 34325761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleic Acid Amplification Test Quantitation as Predictor of Toxin Presence in Clostridium difficile Infection.
    Crobach MJT; Duszenko N; Terveer EM; Verduin CM; Kuijper EJ
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29237788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid detection assay of toxigenic Clostridioides difficile through PathOC RightGene, a novel high-speed polymerase chain reaction device.
    Okanda T; Mitsutake H; Aso R; Sekizawa R; Takemura H; Matsumoto T; Nakamura S
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115247. PubMed ID: 33188946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan.
    Chang FC; Liu CP; Sun FJ; Lin CC
    J Microbiol Immunol Infect; 2021 Apr; 54(2):284-289. PubMed ID: 31624018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter Prevalence Study Comparing Molecular and Toxin Assays for Clostridioides difficile Surveillance, Switzerland.
    Widmer AF; Frei R; Kuijper EJ; Wilcox MH; Schindler R; Spaniol V; Goldenberger D; Egli A; Tschudin-Sutter S
    Emerg Infect Dis; 2020 Oct; 26(10):2370-2377. PubMed ID: 32946368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Searching for a Potential Algorithm for Clostridium difficile Testing at a Tertiary Care Hospital: Does Toxin Enzyme Immunoassay Testing Help?
    Theiss AM; Balla A; Ross A; Francis D; Wojewoda C
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743303
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of 4 molecular assays as part of a 2-step algorithm for the detection of Clostridium difficile in stool specimens.
    Caulfield AJ; Bolster LaSalle CM; Chang YH; Grys TE
    Diagn Microbiol Infect Dis; 2018 May; 91(1):1-5. PubMed ID: 29428547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.
    Barkin JA; Nandi N; Miller N; Grace A; Barkin JS; Sussman DA
    Dig Dis Sci; 2012 Oct; 57(10):2592-9. PubMed ID: 22576711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.